Skip to content

Clinical trials

Sarcoma, Ewing trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma, Ewing Country / region: China Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20151
20161
20171
20183
20201
20211
20246
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed4
Unknown status4
Active, not recruiting3
Not yet recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital11
Fudan University2
Shenzhen Geno-Immune Medical Institute2
Beijing Konruns Pharmaceutical Co., Ltd.1
Essen Biotech1
Hangzhou DAC Biotechnology Co., Ltd.1
Hoffmann-La Roche1
Shanghai Pharmaceuticals Holding Co., Ltd1
Sun Yat-sen University1
Yizhuo Zhang1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma, Ewing22
Osteosarcoma7
Sarcoma7
Bone Neoplasms4
Chondrosarcoma2
Neoplasm Metastasis2
Recurrence2
Brain Neoplasms1
Central Nervous System Neoplasms1
Glioma1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.